Brainomix, a UK-based brain imaging diagnostics software spinout from University of Oxford, has raised an unspecified amount from Parkwalk Advisors, a fund management firm owned by commercialisation company IP Group.
Parkwalk Advisors participated through its Opportunities EIS Fund, which receives tax relief under a UK government scheme for investors.
Founded in 2010, Brainomix has developed artificial intelligence-based diagnostics software that helps identify signs of acute ischemic stroke so that eligible patients can receive prompt and potentially life-saving treatment.
The platform…
